(Q34590013)

3 August 2017

1 reference

title

Treatment of documented and suspected neutropenia-associated invasive fungal infections (English)

1 reference

invasive fungal infections

3 August 2017

main subject

1 reference

De Pauw BE

1

1 reference

3 August 2017

publication date

1 November 2001

1 reference

3 August 2017

published in

Journal of Chemotherapy

1 reference

3 August 2017

volume

13 Spec No 1

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

181-192

1 reference

Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Practical modalities for prevention of fungal infections in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Lung abscess due to Pseudallescheria boydii in the course of acute leukaemia. Report of a case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Hepatic candidiasis in cancer patients: the evolving picture of the syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Computerized tomography in the diagnosis of systemic candidiasis in patients with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Hepatosplenic candidiasis: successful treatment with fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Aspergillus fumigatus pneumonia in neutropenic patients during therapy with fluconazole for infection due to Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

High-dose fluconazole therapy in patients with severe fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Amphotericin B colloidal dispersion for treatment of candidemia in immunocompromised patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Itraconazole as Salvage Therapy in Invasive Pulmonary Aspergillosis Occurring during Amphotericin B Therapy in Neutropenic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Amphotericin B versus amphotericin B plus 5-flucytosine: Poor results in the treatment of proven systemic mycoses in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.SUPPLEMENT-2.181

10.1179/JOC.2001.13.SUPPLEMENT-2.181

21 January 2018

Identifiers

DOI

0 references

1 reference